Alto Neuroscience, Inc. (ANRO)
NYQ – Real Time Price. Currency in USD
27.04
+1.74 (6.88%)
At close: Jun 26, 2026, 4:00 PM EDT
26.50
-0.54 (-2.00%)
After-hours: Jun 26, 2026, 5:55 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
27.04
+1.74 (6.88%)
At close: Jun 26, 2026, 4:00 PM EDT
26.50
-0.54 (-2.00%)
After-hours: Jun 26, 2026, 5:55 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 20.52 | 6.05 | 10 | |
| Quick ratio | 20.52 | 5.63 | 10 | |
| Debt to Equity | 0.10 | 0.30 | 9.0 | |
| Debt to Assets | 0.08 | 1.04 | 9.0 | |
| Interest coverage | -49.79 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -342K | -373K | -502K | -661K | -605K |
| Operating Income | -29M | -38M | -69M | -66M | -78M |
| Net Income | -28M | -36M | -61M | -63M | -74M |
| EBITDA | -29M | -37M | -68M | -66M | -77M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -10.51 | 1.0 |
| Next quarter | N/A | -42.47 | 1.0 |
| Current year | N/A | -36.91 | 1.0 |
| Next year | N/A | -7.64 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -62.13 | -73.9 | -140.06 | 3.3 |
| Y/Y | 999 | -72.95 | -42.85 | -66.74 | 3.3 |
| 3y average | 999 | -34.37 | 43.36 | -37.02 | 5.5 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $263.8M significantly exceed its total debt $23.2M, ensuring strong financial flexibility
Total current assets $269.1M exceed Total current liabilities $13.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-49.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$27.6M limits the company's ability to reinvest or pay down debt